These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34207816)

  • 1. Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease.
    Lu CL; Zheng CM; Lu KC; Liao MT; Wu KL; Ma MC
    Antioxidants (Basel); 2021 Jun; 10(6):. PubMed ID: 34207816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate is a nephro-vascular toxin.
    Niwa T
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of carbon adsorbent in the conservative management of chronic kidney disease.
    Niwa T
    Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoxyl sulfate induces nephrovascular senescence.
    Niwa T; Shimizu H
    J Ren Nutr; 2012 Jan; 22(1):102-6. PubMed ID: 22200425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremic toxicity of indoxyl sulfate.
    Niwa T
    Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
    Watanabe H; Enoki Y; Maruyama T
    Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
    Hamano H; Ikeda Y; Watanabe H; Horinouchi Y; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    Nephrol Dial Transplant; 2018 Apr; 33(4):586-597. PubMed ID: 28992067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant.
    Miyamoto Y; Watanabe H; Otagiri M; Maruyama T
    Ther Apher Dial; 2011 Apr; 15(2):129-31. PubMed ID: 21426502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of uremic toxins on low bone turnover disease in chronic kidney disease.
    Yiang GT; Su WL; Zheng CM; Liao MT; Cheng TH; Lu CL; Lu KC
    Tzu Chi Med J; 2024; 36(1):38-45. PubMed ID: 38406573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo.
    Tsai LT; Weng TI; Chang TY; Lan KC; Chiang CK; Liu SH
    Antioxidants (Basel); 2023 Oct; 12(11):. PubMed ID: 38001784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
    Fujii H; Nakai K; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease.
    Hung KC; Yao WC; Liu YL; Yang HJ; Liao MT; Chong K; Peng CH; Lu KC
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways.
    Tanaka H; Iwasaki Y; Yamato H; Mori Y; Komaba H; Watanabe H; Maruyama T; Fukagawa M
    Bone; 2013 Oct; 56(2):347-54. PubMed ID: 23851293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption.
    Watanabe K; Tominari T; Hirata M; Matsumoto C; Hirata J; Murphy G; Nagase H; Miyaura C; Inada M
    FEBS Open Bio; 2017 Aug; 7(8):1178-1185. PubMed ID: 28781957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats.
    Nakagawa N; Hasebe N; Sumitomo K; Fujino T; Fukuzawa J; Hirayama T; Kikuchi K
    Am J Nephrol; 2006; 26(5):455-61. PubMed ID: 17057375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spherical carbon adsorbent (AST-120) protects deterioration of renal function in chronic kidney disease rats through inhibition of reactive oxygen species production from mitochondria and reduction of serum lipid peroxidation.
    Owada S; Maeba T; Sugano Y; Hirayama A; Ueda A; Nagase S; Goto S; Nishijima F; Bannai K; Yamato H
    Nephron Exp Nephrol; 2010; 115(4):e101-11. PubMed ID: 20424488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.